can tirzepatide cause weight gain Stopping GLP-1s: Regain and Maintenance Tips Before and after tirzepatide weight

GIP, on the other hand, contributes to insulin regulation and has been shown to play a role in reducing appetite as well

"Obesity, like many other chronic diseases, is a progressive, relapsing disease, which may require long-term treatment," Jaisinghani says a framing now codified in the World Health Organization's first global GLP-1 guideline, issued in December 2025, which conditionally recommends these therapies as part of a comprehensive obesity treatment approach

dose-dependent tolerability

FLOW trial: In participants with type 2 diabetes and chronic kidney disease, weekly semaglutide treatment substantially reduced risks of heart failure events or cardiovascular death

Most men report side effects diminish by week 3-4 as the body adapts